Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment

N. Doss; M. -R. Kamoun; L. Dubertret; F. Cambazard; A. Remitz; M. Lahfa; Y. de Prost

doi:10.1111/j.1399-3038.2009.00895.x

Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment

N. Doss, M. -R. Kamoun, L. Dubertret, F. Cambazard, A. Remitz, M. Lahfa, Y. de Prost

Department of Dermatology, Allergology and Venereology

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Pediatric Allergy and Immunology
Volume	21
Pages (from-to)	321-329
Number of pages	9
ISSN	0905-6157
DOIs	https://doi.org/10.1111/j.1399-3038.2009.00895.x
Publication status	Published - 2010
MoE publication type	A1 Journal article-refereed

Fields of Science

atopic dermatitis
children
clinical trial
fluticasone propionate ointment
tacrolimus ointment
HYDROCORTISONE ACETATE
SAFETY
ECZEMA
CYCLOSPORINE
PATHOGENESIS
0.05-PERCENT
0.1-PERCENT
312 Clinical medicine

Access to Document

10.1111/j.1399-3038.2009.00895.x

Cite this

Doss, N., Kamoun, M. .-R., Dubertret, L., Cambazard, F., Remitz, A., Lahfa, M., & de Prost, Y. (2010). Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment. Pediatric Allergy and Immunology, 21, 321-329. https://doi.org/10.1111/j.1399-3038.2009.00895.x

@article{a1196d117d884714a35eabb195965a02,

title = "Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment",

keywords = "atopic dermatitis, children, clinical trial, fluticasone propionate ointment, tacrolimus ointment, HYDROCORTISONE ACETATE, SAFETY, ECZEMA, CYCLOSPORINE, PATHOGENESIS, 0.05-PERCENT, 0.1-PERCENT, 312 Clinical medicine",

author = "N. Doss and Kamoun, {M. -R.} and L. Dubertret and F. Cambazard and A. Remitz and M. Lahfa and {de Prost}, Y.",

year = "2010",

doi = "10.1111/j.1399-3038.2009.00895.x",

language = "English",

volume = "21",

pages = "321--329",

journal = "Pediatric Allergy and Immunology",

issn = "0905-6157",

publisher = "Wiley",

}

Doss, N, Kamoun, M-R, Dubertret, L, Cambazard, F, Remitz, A, Lahfa, M & de Prost, Y 2010, 'Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment', Pediatric Allergy and Immunology, vol. 21, pp. 321-329. https://doi.org/10.1111/j.1399-3038.2009.00895.x

Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment. / Doss, N.; Kamoun, M. -R.; Dubertret, L. et al.
In: Pediatric Allergy and Immunology, Vol. 21, 2010, p. 321-329.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment

AU - Doss, N.

AU - Kamoun, M. -R.

AU - Dubertret, L.

AU - Cambazard, F.

AU - Remitz, A.

AU - Lahfa, M.

AU - de Prost, Y.

PY - 2010

Y1 - 2010

KW - atopic dermatitis

KW - children

KW - clinical trial

KW - fluticasone propionate ointment

KW - tacrolimus ointment

KW - HYDROCORTISONE ACETATE

KW - SAFETY

KW - ECZEMA

KW - CYCLOSPORINE

KW - PATHOGENESIS

KW - 0.05-PERCENT

KW - 0.1-PERCENT

KW - 312 Clinical medicine

U2 - 10.1111/j.1399-3038.2009.00895.x

DO - 10.1111/j.1399-3038.2009.00895.x

M3 - Article

SN - 0905-6157

VL - 21

SP - 321

EP - 329

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

ER -

Doss N, Kamoun MR, Dubertret L, Cambazard F, Remitz A, Lahfa M et al. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment. Pediatric Allergy and Immunology. 2010;21:321-329. doi: 10.1111/j.1399-3038.2009.00895.x